Salva, Kim Bailey F.

HRN: 26-93-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CEFTRIAXONE 1G (VIAL)
04/08/2025
04/15/2025
IV
500mg
OD
PCAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Final appropriateness: Yes   

Overall appropriateness: Yes